---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-056928"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T05:29:28.033774+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Arcadia Q1 2024 revenue up 2% YoY; net loss narrows to $2.4M from $9.4M

## Summary
- Product revenue $1.255M (+2% YoY); fifth consecutive quarter with >30% gross margin.
- Loss from continuing ops improved 21% to $3.064M; lowest in 6 years.
- Net loss $2.423M ($1.78/share) vs $9.384M ($10.86/share) in Q1 2023, helped by absence of PIPE valuation loss.
- GoodWheat in 3,500+ stores; Zola added ~200 stores in Q1, set to ship to ~1,300 more in Q2.
- Cash & short-term investments $8.5M; operating cash burn $3.21M in quarter.

## SEC filing metadata
- accession: 0000950170-24-056928
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017024056928/0000950170-24-056928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017024056928/rkda-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-056928
- JSON: https://secwatch.observer/filing/0000950170-24-056928.json
- Plain text: https://secwatch.observer/filing/0000950170-24-056928.txt

## Key facts
- Earnings Releases
  Arcadia Biosciences, Inc. reported financial results for the first quarter ended March 31, 2024.
  - Period: the first quarter ended March 31, 2024
  - Result: reported results
  source text: On May 9, 2024 Arcadia Biosciences, Inc. (the “Company”) issued a press release announcing financial results for the first quarter ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017024056928/0000950170-24-056928-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.